1832 Asset Management
PJP icon

1832 Asset Management’s Invesco Pharmaceuticals ETF PJP Stock Holding History

1832 Asset Management’s Portfolio PJP Stock Details PJP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-100
Closed -$8K – 681
2015
Q2 		$8K Buy
+100
New +$7.78K ﹤0.01% 597

Other funds holding PJP

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
FIG
FundX Investment Group San Francisco, California $411M AUM 22.05% 1-Year Est. Return
NFC
Northeast Financial Consultants Westport, Connecticut $2.45B AUM 15.14% 1-Year Est. Return
PAM
Peak Asset Management Louisville, Colorado $680M AUM 22.27% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

1832 Asset Management's PJP Position: Q3 2015 in Review

1832 Asset Management sold out of Invesco Pharmaceuticals ETF (PJP) in Q3 2015, closing a stake of 100 shares — an estimated $8K sold.

1832 Asset Management first reported a position in PJP in Q2 2015 and held it in 1 quarter. The position peaked at $8K in Q2 2015. 106 funds tracked by Wall St. Rank hold PJP as of Q3 2015.

  • 1832 Asset Management reported no remaining Invesco Pharmaceuticals ETF position as of Q3 2015 after selling out during the quarter.
  • 1832 Asset Management sold 100 Invesco Pharmaceuticals ETF shares in Q3 2015, an estimated $8K.
  • 1832 Asset Management first reported a position in Invesco Pharmaceuticals ETF in Q2 2015 and held it in 1 quarter.
  • 1832 Asset Management's Invesco Pharmaceuticals ETF position peaked at $8K in Q2 2015.
  • 106 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q3 2015.

Based on 1832 Asset Management's 13F filing for Q3 2015, filed 12 Nov 2015.